Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when he plans to publish the report on packaging changes to Selective serotonin reuptake inhibitors, as discussed at the Commission on Human Medicines Antidepressant Risk Minimisation Expert Working Group on 1 May.

A public assessment report will be published by the Medicines and Healthcare products Regulatory Agency (MHRA) after the completion of the review. The advice of the Commission on Human Medicines (CHM) will be sought after the next meeting of the Antidepressant Risk Minimisation Expert Working Group (EWG) in July 2025.

The public assessment report will contain the minutes of all EWG meetings and the CHM’s advice on any regulatory action required. It is anticipated that the public assessment report will be published by the MHRA in Autumn 2025.